Cargando…

Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients

OBJECTIVES: Large-scale clinical studies investigating associations between intestinal microbiota signatures and human diseases usually rely on stool samples. However, the timing of repeated stool sample collection cannot be predefined in longitudinal settings. Rectal swabs, being straightforward to...

Descripción completa

Detalles Bibliográficos
Autores principales: Biehl, Lena M., Garzetti, Debora, Farowski, Fedja, Ring, Diana, Koeppel, Martin B., Rohde, Holger, Schafhausen, Philippe, Stecher, Bärbel, Vehreschild, Maria J. G. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464231/
https://www.ncbi.nlm.nih.gov/pubmed/30986251
http://dx.doi.org/10.1371/journal.pone.0215428
_version_ 1783410845467803648
author Biehl, Lena M.
Garzetti, Debora
Farowski, Fedja
Ring, Diana
Koeppel, Martin B.
Rohde, Holger
Schafhausen, Philippe
Stecher, Bärbel
Vehreschild, Maria J. G. T.
author_facet Biehl, Lena M.
Garzetti, Debora
Farowski, Fedja
Ring, Diana
Koeppel, Martin B.
Rohde, Holger
Schafhausen, Philippe
Stecher, Bärbel
Vehreschild, Maria J. G. T.
author_sort Biehl, Lena M.
collection PubMed
description OBJECTIVES: Large-scale clinical studies investigating associations between intestinal microbiota signatures and human diseases usually rely on stool samples. However, the timing of repeated stool sample collection cannot be predefined in longitudinal settings. Rectal swabs, being straightforward to obtain, have the potential to overcome this drawback. Therefore, we assessed the usability of rectal swabs for microbiome sampling in a cohort of hematological and oncological patients. STUDY DESIGN: We used a pipeline for intestinal microbiota analysis from deep rectal swabs which was established and validated with test samples and negative controls. Consecutively, a cohort of patients from hematology and oncology wards was established and weekly deep rectal swabs taken during their admissions and re-admissions. RESULTS: Validation of our newly developed pipeline for intestinal microbiota analysis from rectal swabs revealed consistent and reproducible results. Over a period of nine months, 418 rectal swabs were collected longitudinally from 41 patients. Adherence to the intended sampling protocol was 97%. After DNA extraction, sequencing, read pre-processing and filtering of chimeric sequences, 405 of 418 samples (96.9%) were eligible for further analyses. Follow-up samples and those taken under current antibiotic exposure showed a significant decrease in alpha diversity as compared to baseline samples. Microbial domination occurred most frequently by Enterococcaceae (99 samples, 24.4%) on family level and Enterococcus (90 samples, 22.2%) on genus level. Furthermore, we noticed a high abundance of potential skin commensals in 99 samples (24.4%). SUMMARY: Deep rectal swabs were shown to be reliable for microbiome sampling and analysis, with practical advantages related to high sampling adherence, easy timing, transport and storage. The relatively high abundance of putative skin commensals in this patient cohort may be of potential interest and should be further investigated. Generally, previous findings on alpha diversity dynamics obtained from stool samples were confirmed.
format Online
Article
Text
id pubmed-6464231
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64642312019-05-03 Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients Biehl, Lena M. Garzetti, Debora Farowski, Fedja Ring, Diana Koeppel, Martin B. Rohde, Holger Schafhausen, Philippe Stecher, Bärbel Vehreschild, Maria J. G. T. PLoS One Research Article OBJECTIVES: Large-scale clinical studies investigating associations between intestinal microbiota signatures and human diseases usually rely on stool samples. However, the timing of repeated stool sample collection cannot be predefined in longitudinal settings. Rectal swabs, being straightforward to obtain, have the potential to overcome this drawback. Therefore, we assessed the usability of rectal swabs for microbiome sampling in a cohort of hematological and oncological patients. STUDY DESIGN: We used a pipeline for intestinal microbiota analysis from deep rectal swabs which was established and validated with test samples and negative controls. Consecutively, a cohort of patients from hematology and oncology wards was established and weekly deep rectal swabs taken during their admissions and re-admissions. RESULTS: Validation of our newly developed pipeline for intestinal microbiota analysis from rectal swabs revealed consistent and reproducible results. Over a period of nine months, 418 rectal swabs were collected longitudinally from 41 patients. Adherence to the intended sampling protocol was 97%. After DNA extraction, sequencing, read pre-processing and filtering of chimeric sequences, 405 of 418 samples (96.9%) were eligible for further analyses. Follow-up samples and those taken under current antibiotic exposure showed a significant decrease in alpha diversity as compared to baseline samples. Microbial domination occurred most frequently by Enterococcaceae (99 samples, 24.4%) on family level and Enterococcus (90 samples, 22.2%) on genus level. Furthermore, we noticed a high abundance of potential skin commensals in 99 samples (24.4%). SUMMARY: Deep rectal swabs were shown to be reliable for microbiome sampling and analysis, with practical advantages related to high sampling adherence, easy timing, transport and storage. The relatively high abundance of putative skin commensals in this patient cohort may be of potential interest and should be further investigated. Generally, previous findings on alpha diversity dynamics obtained from stool samples were confirmed. Public Library of Science 2019-04-15 /pmc/articles/PMC6464231/ /pubmed/30986251 http://dx.doi.org/10.1371/journal.pone.0215428 Text en © 2019 Biehl et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Biehl, Lena M.
Garzetti, Debora
Farowski, Fedja
Ring, Diana
Koeppel, Martin B.
Rohde, Holger
Schafhausen, Philippe
Stecher, Bärbel
Vehreschild, Maria J. G. T.
Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title_full Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title_fullStr Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title_full_unstemmed Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title_short Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
title_sort usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464231/
https://www.ncbi.nlm.nih.gov/pubmed/30986251
http://dx.doi.org/10.1371/journal.pone.0215428
work_keys_str_mv AT biehllenam usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT garzettidebora usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT farowskifedja usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT ringdiana usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT koeppelmartinb usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT rohdeholger usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT schafhausenphilippe usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT stecherbarbel usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients
AT vehreschildmariajgt usabilityofrectalswabsformicrobiomesamplinginacohortstudyofhematologicalandoncologicalpatients